Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats

Pharmacology

Volumn 87, Issue 3-4, 2011, Pages 232-240

  Heeba, Gehan H ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Angiotensin II; Gentamicin; Losartan; Nephrotoxicity, rats; Oxidative stress

Indexed keywords

ANGIOTENSIN RECEPTOR; CATALASE; CREATININE; GENTAMICIN; GLUTATHIONE; LOSARTAN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG INDUCED DISEASE; KIDNEY INJURY; NEPHROTOXICITY; NONHUMAN; OLIGURIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; GENTAMICINS; GLUTATHIONE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPID PEROXIDES; LOSARTAN; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 79953701676     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000325457     Document Type: Article

References (44)

1. Martínez-Salgado C, López-Hernández FJ, López-Novoa JM: Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007; 223: 86-98. (Pubitemid 47211265)
2. Edson RS, Terrell CL: The aminoglycosides. Mayo Clin Proc 1999; 74: 519-528. (Pubitemid 29207153)
3. Wiland P, Szechcinski J: Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol 2003; 55: 631-637. (Pubitemid 37185368)
4. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D: A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 2002; 450: 67-76.
5. Nakajima T, Hishida A, Kato A: Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am J Physiol 1994; 266: 425-431.
6. Karahan I, Atessahin A, Yilmaz S, Ceribas AOC, Sakin F: Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology 2005; 215: 98-204.
7. López-Novoa JM, Quiros Y, Vicente L, Morales AI, López-Hernàndez FJ: New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 79: 33-45.
8. Parlakpinar H, Tasdemir S, Polat A, Bay- Karabulut A, Vardi N, Ucar M, Acet A: Protective role of caffeic acid phenethyl ester on gentamicin-induced acute renal toxicity in rats. Toxicology 2005; 207: 169-177. (Pubitemid 39642833)
9. Abdel-Naim AB, Abdel-Wahab MH, Attia FF: Protective effects of vitamin E and probucol against gentamicin-induced nephrotoxicity in rats. Pharmacol Res 1999; 40: 183-187. (Pubitemid 29378100)
10. Pedraza-Chaverri J, Gonzalez-Orozco AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R: Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats. Eur J Pharmacol 2003; 473: 71-78. (Pubitemid 36851630)
11. Harris RC, Martínez-Maldonado M: Angiotensin II-mediated renal injury. Miner Electrolyte Metab 1995; 21: 328-335.
12. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 2001; 38: 635-638.
13. Julien J, Farge D, Kreft-Jais C, Guyene TT, Plouin PF, Houssin D, Carpentier A, Corvol P: Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 1993; 56: 885-891. (Pubitemid 23321524)
14. Edwards BD, Chalmers RJ, O'Driscoll JB, Mitchell DM, Smith RJ, Lawson RS, Testa HJ, Ballardie FW: Angiotensin II as a risk factor for cyclosporine nephrotoxicity in patients with psoriasis. Clin Nephrol 1994; 41: 350-356. (Pubitemid 24176923)
15. Avdonin PV, Cottet-Maire F, Afanasjeva GV, Loktionova SA, Lhote P, Ruegg UT: Cyclosporine A upregulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells. Kidney Int 1999; 55: 2407-2414. (Pubitemid 29256495)
16. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 2002; 62:S12-S22. (Pubitemid 35356990)
17. Liao TD, Yang XP, Liu YH, Shesely EG, Cavasin MA, Kuziel WA, Pagano PJ, Carretero OA: Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Role of inflammation in the development of renal damage and dysfunction in angiotensin II induced hypertension. Hypertension 2008; 52: 256-263.
18. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1988; 54: 775-784.
19. Wilson SK: Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rats. Circ Res 1990; 66: 722-734.
20. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, Chappell MC: The angiotensin II-AT 1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 2009; 384: 149-154.
21. Padi SSV, Chopra K: Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 2002; 45: 413-420. (Pubitemid 35304508)
22. Anderson S, Komers R: Inhibition of the renin- angiotensin system: is more better? Kidney Int 2009; 75: 12-14.
23. Teles F, Machado FG, Ventura BH, Malheiros DM, Fujihara CK, Silva LF: Regression of glomerular injury by losartan in experimental diabetic nephropathy. Kidney Int 2009; 75: 72-79.
24. Fierens FLP, Vanderheyden PML, De Backer JP, Vauquelin G: Insurmountable angiotensin AT 1 receptor antagonists: the role of tight antagonist binding. Eur J Pharmacol 1996; 372: 199-206. (Pubitemid 29251292)
25. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM: Prevention of experimental cyclosporine- induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269:F491-F499.
26. Deegan PM, Nolan C, Ryan MP, Basinger MA, Jones MM, Hande KR: The role of the renin-angiotensin system in cisplatin nephrotoxicity. Ren Fail 1995; 17: 665-674.
27. Saleh S, Ain-Shoka AA, El-Demerdash E, Khalef MM: Protective effects of the angiotensin II receptor blocker losartan on cisplatin- induced kidney injury. Chemotherapy 2009; 55: 399-406.
28. Fawcett JK, Scott JE: A rapid and precise method for the determination of urea. J Clin Pathol 1960; 13: 156-159.
29. Bartles H, Bohmer M, Heirli C: Serum creatinine determination without protein precipitation. Clin Chem Acta 1972; 37: 193-197.
30. Uchiyama M, Mihara M: Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1979; 86: 271-278.
31. Beutler E, Duron O, Kelly MB: Improved method for determination of blood glutathione. J Lab Clin Med 1963; 61: 882-887.
32. Aebi H: Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
33. Nishikimi M, Appaji N, Yagi k: The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972; 46: 849-854.
34. Soliman KM, Abdul-Hamid M, Othman AI: Effect of carnosine on gentamicin-induced nephrotoxicity. Med Sci Monit 2007; 13: 73-83.
35. Atessahin A, Karahan I, Yilmaz S, Ceribasi A, Princci I: The effect of manganese chloride on gentamicin-induced nephrotoxicity in rats. Pharmacol Res 2003; 48: 637-642. (Pubitemid 38352783)
36. Priuska EM, Schacht J: Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 1995; 50: 1749-1752. (Pubitemid 26011387)
37. Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R, Ibarra Rubio ME, Pedraza-Chaverri J: Aged garlic extract attenuates gentamicin-induced renal damage and oxidative stress in rats. Life Sci 2003; 73: 2543-2556. (Pubitemid 37098297)
38. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T: Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 1999; 55: 252-260. (Pubitemid 29004257)
39. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-1923.
40. Touyz R, Schiffrin E: Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999; 34: 976-982. (Pubitemid 29501333)
41. Zalba G, Beaumont FJ, San-Jose G, Fortuno A, Fortuno MA, Etayo JC, Diez J: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061. (Pubitemid 30327257)
42. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B: Intra-renal angiotensin II/AT 1 receptor, oxidative stress, inflammation and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007; 323: 85-93. (Pubitemid 47443257)
43. Portero-Otin M, Pamplona R, Boada J, Jove M, Gonzalo H, Buleon M, Linz W, Schafer S, Tack I, Girolami JP: Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem Biophys Res Commun 2008; 368: 528-535.
44. Ibrahim MA, Ashour OM, Ibrahim YF, El-Bitar HI, Gomaa W, Abdel-Rahim SR: Angiotensin-converting enzyme inhibition and angiotensin AT 1 -receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol Res 2009; 60: 373-381.